2005
Please click on the title to view the abstract and publication
source for each paper, as listed on 'www.pubmed.com'.
Iodine
excretion in regions of Ukraine affected by the Chornobyl
Accident: experience of the Ukrainian-American cohort
study of thyroid cancer and other thyroid diseases.
Tronko M, Kravchenko V, Fink D, Hatch M, Turchin V, McConnell
R, Shpak V, Brenner A, Robbins J, Lusanchuk I, Howe G.
Thyroid. 2005 Nov;15(11):1291-7.
Permanent
hypoparathyroidism due to thyroid cancer surgical procedures
in patients exposed to radiation in the Chernobyl, Ukraine,
nuclear reactor accident.
Bohrer T, Pasteur I, Lyutkevych O, Fleischmann P, Tronko
M.
Dtsch Med Wochenschr. 2005 Nov 4;130(44):2501-6. German.
Chernobyl:
poverty and stress pose 'bigger threat' than radiation.
Stephan V.
Nature. 2005 Sep 8;437(7056):181.
Gene
expression profiling in human thyroid tumors.
Maenhaut C.
Bull Mem Acad R Med Belg. 2004;159(10-12):533-9; discussion
539-40. French.
Incidence
of thyroid cancer in the population of the Bryansk Region
after the Chernobyl nuclear plant accident.
Zvonova IA, Bramilova AA, Pochtennaia GT, Petrova GV.
Vopr Onkol. 2005;51(5):540-5. Russian.
Radiation-induced
thyroid cancer--what's new?
Boice JD Jr.
J Natl Cancer Inst. 2005 May 18;97(10):703-5. Review.
Risk
of thyroid cancer after exposure to 131I in childhood.
Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata
Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov
O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko
J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito
M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V,
Nerovnia A, Parshin V, Parshkov E, Piliptsevich N, Pinchera
A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita
S, Williams D.
J Natl Cancer Inst. 2005 May 18;97(10):724-32.
Uncertainty
and sensitivity analysis in assessment of the thyroid
cancer risk related to chernobyl fallout in eastern france.
Catelinois O, Laurier D, Verger P, Rogel A, Colonna M,
Ignasiak M, Hemon D, Tirmarche M.
Risk Anal. 2005 Apr;25(2):243-52.
Absence
of a specific radiation signature in post-Chernobyl thyroid
cancers.
Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T,
Tronko MD, Dumont JE, Franc B, Thomas G, Maenhaut C.
Br J Cancer. 2005 Apr 25;92(8):1545-52.
ret/PTC1
and ret/PTC3 in thyroid tumors from Chernobyl liquidators:
comparison with sporadic tumors from Ukrainian and French
patients.
Di Cristofaro J, Vasko V, Savchenko V, Cherenko S, Larin
A, Ringel MD, Saji M, Marcy M, Henry JF, Carayon P, De
Micco C.
Endocr Relat Cancer. 2005 Mar;12(1):173-83.
Investigation
of loss of heterozygosity and SNP frequencies in the RET
gene in papillary thyroid carcinoma.
Stephens LA, Powell NG, Grubb J, Jeremiah SJ, Bethel JA,
Demidchik EP, Bogdanova TI, Tronko MD, Thomas GA.
Thyroid. 2005 Feb;15(2):100-4.
Frequency
of BRAF T1796A mutation in papillary thyroid carcinoma
relates to age of patient at diagnosis and not to radiation
exposure.
Powell N, Jeremiah S, Morishita M, Dudley E, Bethel J,
Bogdanova T, Tronko M, Thomas G.
J Pathol. 2005 Apr;205(5):558-64.
Post-Chornobyl
thyroid cancers in Ukraine. Report 1: estimation of thyroid
doses.
Likhtarov I, Kovgan L, Vavilov S, Chepurny M, Bouville
A, Luckyanov N, Jacob P, Voilleque P, Voigt G.
Radiat Res. 2005 Feb;163(2):125-36.
Oncogenic
AKAP9-BRAF fusion is a novel mechanism of MAPK pathway
activation in thyroid cancer.
Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova
MN, Rabes HM, Fagin JA, Nikiforov YE.
J Clin Invest. 2005 Jan;115(1):94-101.
A
new mechanism of BRAF activation in human thyroid papillary
carcinomas.
Fusco A, Viglietto G, Santoro M.
J Clin Invest. 2005 Jan;115(1):20-3.
